IQVIA Holdings Inc.
IQV
Hisse Senetlerindeki Sıralama
#561
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Hisse Fiyatı
$266.90
Son senkronizasyon: 2026-10-16
Piyasa Değeri
$43.93B
Değişim (1 gün)
-1.32%
Değişim (1 yıl)
30.48%
Ülke
US
Ticaret IQVIA Holdings Inc. (IQV)
Kategori
Healthcare
IQVIA Holdings Inc. (IQV) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 13.57%
IQVIA Holdings Inc. şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 13.57%'dir. 2024 yılı sonunda şirketin faaliyet marjı 14.29% idi.
IQVIA Holdings Inc. için 2010 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
| Yıl | Faaliyet Marjı | Değiştir |
|---|---|---|
| 2026 (TTM) | 13.57% | -3.21% |
| 2025 | 14.02% | -1.89% |
| 2024 | 14.29% | 8.34% |
| 2023 | 13.19% | 5.69% |
| 2022 | 12.48% | 24.30% |
| 2021 | 10.04% | 55.90% |
| 2020 | 6.44% | -8.13% |
| 2019 | 7.01% | -1.54% |
| 2018 | 7.12% | -3.91% |
| 2017 | 7.41% | -21.34% |
| 2016 | 9.42% | -16.42% |
| 2015 | 11.27% | 4.26% |
| 2014 | 10.81% | 19.18% |
| 2013 | 9.07% | 11.29% |
| 2012 | 8.15% | 2.13% |
| 2011 | 7.98% | -20.75% |
| 2010 | 10.07% | 0.00% |
Benzer şirketler veya rakipler için Faaliyet Marjı
| Şirket | Faaliyet Marjı | Faaliyet Marjı Farkı | Ülke |
|---|---|---|---|
| 17.97% | -98.68% |
US
|
|
| 20.42% | -98.50% |
US
|
|
| -10.70% | -100.79% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -98.36% |
US
|
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.